RCKT
NASDAQStockRocket Pharmaceuticals, Inc.
$4.94-0.01 (-0.30%)
52-Week Range
$2.33
$8.83
Key Stats
Market Cap
536.3M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.45
Volume
1.3M
Avg Volume
3.6M
Performance
1M
+51.85%
3M
+44.28%
6M
+52.80%
YTD
+42.20%
1Y
-42.12%
3Y
-73.73%
5Y
-91.33%
Price Chart
ETF Exposure
RCKT is held by 46 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| BBC | Virtus Biotech Clinical Trials ETF | 1.16% |
| WDNA | WisdomTree BioRevolution Fund | 0.46% |
| JPLD | JPMorgan Limited Duration Bond ETF | 0.30% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.29% |
| JCPB | JPMorgan Core Plus Bond ETF | 0.15% |
| JMTG | JPMorgan Mortgage-Backed Securities ETF | 0.12% |
| JBND | JPMorgan Active Bond ETF | 0.11% |
| JSCP | JPMorgan Short Duration Core Plus ETF | 0.09% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.08% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.06% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.05% |
| IBB | iShares Biotechnology ETF | 0.05% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
About RCKT ETF Exposure
Rocket Pharmaceuticals, Inc. (RCKT) is held by 46 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 536.3M, RCKT is a widely held institutional stock. The stock currently trades at $4.94. Investors can gain exposure to RCKT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RCKT, sorted by portfolio weight.